SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-004955
Filing Date
2022-02-18
Accepted
2022-02-18 16:00:47
Documents
64
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1342938
2 ex31-1.htm EX-31.1 17584
3 ex31-2.htm EX-31.2 17776
4 ex32-1.htm EX-32.1 11096
  Complete submission text file 0001493152-22-004955.txt   7206195

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE obmp-20211231.xsd EX-101.SCH 57403
6 XBRL CALCULATION FILE obmp-20211231_cal.xml EX-101.CAL 74953
7 XBRL DEFINITION FILE obmp-20211231_def.xml EX-101.DEF 304806
8 XBRL LABEL FILE obmp-20211231_lab.xml EX-101.LAB 484009
9 XBRL PRESENTATION FILE obmp-20211231_pre.xml EX-101.PRE 386451
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1017140
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 22652573
SIC: 2834 Pharmaceutical Preparations